Hologic Stock Beneish M Score

HOLX Stock  USD 75.98  0.27  0.36%   
This module uses fundamental data of Hologic to approximate the value of its Beneish M Score. Hologic M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Hologic Piotroski F Score and Hologic Altman Z Score analysis.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
  
At this time, Hologic's Short and Long Term Debt is fairly stable compared to the past year. Debt To Equity is likely to rise to 0.54 in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 1.8 B in 2024. At this time, Hologic's Research And Ddevelopement To Revenue is fairly stable compared to the past year. Cash Per Share is likely to rise to 10.49 in 2024, whereas Price To Sales Ratio is likely to drop 2.10 in 2024.
At this time, Hologic's M Score is unavailable. The earnings manipulation may begin if Hologic's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Hologic executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Hologic's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.72
Beneish M Score - Unavailable
Elasticity of Receivables

1.0

Focus
Asset Quality

1.07

Focus
Expense Coverage

1.0

Focus
Gross Margin Strengs

0.85

Focus
Accruals Factor

1.0

Focus
Depreciation Resistance

0.67

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

0.99

Focus

Hologic Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Hologic's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables755.4 M719.4 M
Sufficiently Up
Slightly volatile
Total Revenue4.9 B4.6 B
Sufficiently Up
Slightly volatile
Total Assets11 B10.5 B
Sufficiently Up
Slightly volatile
Total Current Assets5.1 B4.8 B
Sufficiently Up
Slightly volatile
Non Current Assets TotalB5.7 B
Way Down
Pretty Stable
Property Plant Equipment337.5 M666.7 M
Way Down
Slightly volatile
Depreciation And Amortization390.5 M371.9 M
Sufficiently Up
Slightly volatile
Selling General Administrative473.8 M451.3 M
Sufficiently Up
Slightly volatile
Total Current Liabilities1.5 B1.4 B
Sufficiently Up
Slightly volatile
Non Current Liabilities TotalB3.4 B
Way Down
Slightly volatile
Short Term Debt177.8 M330.1 M
Way Down
Very volatile
Long Term Debt2.2 B2.9 B
Way Down
Pretty Stable
Long Term Investments12.8 M13.9 M
Significantly Down
Slightly volatile
Gross Profit Margin0.390.46
Fairly Down
Very volatile

Hologic Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Hologic's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Hologic in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Hologic's degree of accounting gimmicks and manipulations.

About Hologic Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Accumulated Depreciation

(393.62 Million)

Hologic reported Accumulated Depreciation of (374.88 Million) in 2023

Hologic Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Hologic. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables1.0B942.7M617.6M625.6M719.4M755.4M
Total Revenue3.8B5.6B4.9B4.0B4.6B4.9B
Total Assets7.2B8.9B9.1B9.1B10.5B11.0B
Total Current Assets2.2B3.2B3.9B4.2B4.8B5.1B
Net Debt2.3B1.9B483.9M95.7M110.1M104.6M
Short Term Debt324.9M313M15M287M330.1M177.8M
Long Term Debt2.7B2.7B2.8B2.5B2.9B2.2B
Operating Income1.1B2.5B1.6B668.4M768.7M807.1M
Investments(141.6M)(1.3B)(206.3M)(152.1M)(136.9M)(143.7M)

Hologic ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Hologic's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Hologic's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

About Hologic Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Hologic Piotroski F Score and Hologic Altman Z Score analysis.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.373
Earnings Share
2.11
Revenue Per Share
16.228
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0649
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.